Moreover, MAO A and MAO B inhibitors were found to decrease the glioma progression [17,45,46], supporting the hypothesis of a critical role played by MAOs in mediating oncogenesis in high-grade gliomas [46]. Here, MAOB is linked to central nervous system cancer.